Tiny particles of albumin, a protein found in the blood, can be used to carry radioactive isotopes to the site of a cancerous tumour in the body and so avoid many of the side-effects of conventional radiotherapy.
Organized by the Cambridge CNT Society, the 2009 forum on November 13, 2009 in Cambridge, UK, will provide a platform for reviewing and discussing novel developments in the field of carbon nanostructures and related materials as well as their applications.
Der Branchendialog 'NanoEngineering' soll am 8. Dezember 2009 in Duesseldorf zeigen, wie neue Entwicklungen aus der Material- und Nanotechnologieforschung in die Praxis des Maschinen- und Anlagenbaus ueberfuehrt und damit Kosteneinsparungen erzielt sowie neue Maerkte erschlossen werden koennen.
A new grant from the National Science Foundation (NSF) will support 30 graduate students working in the Cornell Center for Materials Research (CCMR) on the development of materials to advance sustainable living.
For decades, researchers have been trying to combine semiconductor materials that have different and potentially complementary characteristics into a single microchip. Now, an MIT team has finally succeeded in this effort, an advance that could point to a way of overcoming fundamental barriers of size and speed facing today's silicon chips.
The Australian research community will soon have access to one of the most powerful nanotechnology instruments in the world, able to write and etch data on particles ten thousand times smaller than the width of a human hair.
Today NorTech, the champion for high tech industry growth in Northeast Ohio, announced it will transition operations of its Nano-Network initiative to PolymerOhio, a statewide organization that accelerates commercialization activities across a wide range of applications in the polymer and advanced materials industries.
The Fraunhofer Institute for Surface Engineering and Thin Films IST has successfully initiated a COST Action on the subject of 'highly ionised pulse plasma processes - HIPP processes' and now takes the lead of the action.
Scientists at Oregon State University have developed a new 'adjuvant' that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.